Investment Summary |
|
|---|---|
| Date | 2019-12-24 |
| Target | VVDN Technologies |
| Sector | Information Technology |
| Investor(s) | Motilal Oswal Private Equity Advisors |
| Deal Type | Growth Capital |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2006 |
| PE ASSETS | 2.1B USD |
| Size | Large |
| Type | Sector Agnostic |
Motilal Oswal Private Equity Advisors is the private equity arm of Motilal Oswal Financial Services Limited, a diversified financial services group. Motilal Oswal Private Equity Advisors looks to invest in and acquire mid-sized growth oriented companies throughout India. The Firm targets businesses in need of capital to to expand into new geographies and products. Motilal Oswal Private Equity Advisors was established in 2006 and is headquartered in Mumbai, Maharashtra.
| DEAL STATS | # |
|---|---|
| Overall | 25 of 37 |
| Sector: Information Technology M&A | 2 of 2 |
| Type: Growth Capital M&A Deals | 13 of 22 |
| Country: India M&A | 23 of 35 |
| Year: 2019 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-12-18 |
Symbiotec Pharmalab
Indore, India Symbiotec Pharmalab is a pharmaceutical company that develops, manufactures, and supplies Active Pharmaceutical Ingredients (APIs), especially cortico‑steroids and steroid‑hormone APIs, for global markets under international quality standards like US FDA, EU GMP, and WHO‑GMP. Symbiotec Pharmalab was founded in 1995 and is based in Indore, Madhya Pradesh. |
Buy | $100M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-03-04 |
Molbio Diagnostics
Verna, India Molbio Diagnostics develops and manufactures rapid, portable PCR-based diagnostic platforms, including the WHO-endorsed Truenat® system. It provides accurate, cost-effective testing for infectious and non-communicable diseases in decentralized and resource-limited settings. Molbio Diagnostics was founded in 2000 and is based in Verna, Goa. |
Buy | - |
